Bond.az White LogoBond.az Black Logo

Jefferies Raises AMAT Target to $510 on AI

Jefferies raises Applied Materials price target to $510, citing AI growth and strong semiconductor outlook.

Robert Moore
ByRobert Moore- Senior Editor
|
0

Bond.az - Jefferies raised its price target on Applied Materials (NASDAQ:AMAT) to $510 from $415, maintaining a Buy rating. The stock trades at $440.56, near its 52-week high of $448.45, following a 154% gain over the past year.

Applied Materials lifted its calendar 2026 semiconductor equipment growth outlook to over 30% from prior over 20%. The company projects continued 20-30% growth through 2027. According to Bond.az data, 25 analysts revised earnings upward.

Customers now provide rolling eight-quarter forecasts extending to 2028. Over 10 new fab projects were added in the past 90 days. Applied Materials said current strength is not pulled forward demand; 2027 should remain strong.

Agentic AI workloads add CPU, DRAM, and NAND demand. New EPIC Center partnerships enable co-innovation with TSMC, Samsung, Micron, and others.

In other news, Applied Materials beat Q2 estimates and guided Q3 revenue above consensus at ~$8.95B. Stifel raised its target to $530, RBC Capital to $520, Mizuho to $500, UBS to $515, and KeyBanc to $550.

More News
Today / 10:42
|
838

Wolfe Research Boosts AMAT Target to $550

Wolfe Research raised Applied Materials price target to $550 from $500, citing strong guidance and revenue growth. Shares have gained 154% in the past year.

0
Today / 10:03
|
707

Citizens Reiterates Uber Stock Rating on EBITDA

Citizens reiterates Market Outperform rating on Uber with $100 target, citing EBITDA growth and autonomous vehicle potential.

0
Today / 10:01
|
662

Citizens Reiterates Charles Schwab Stock Rating

Citizens maintains Market Outperform rating on Charles Schwab with $120 price target after investor day. AI viewed as net positive.

0
Today / 10:00
|
634

BofA hikes Applied Materials target to $540

BofA raises Applied Materials price target to $540 from $465, citing strong outlook and record quarterly results.

0
Today / 09:54
|
881

Goldman Sachs cuts Regenxbio target to $10

Goldman Sachs cuts Regenxbio (NASDAQ:RGNX) price target to $10 from $12 on RGX-202 regulatory uncertainty. Stock down 41% to $6.25.

0
Today / 09:53
|
570

Citizens Raises Bandwidth Stock Price Target

Citizens raises Bandwidth price target to $70 from $45, citing AI voice opportunity and Salesforce selection. Stock up 257% in past year.

0
Today / 09:52
|
336

Goldman Sachs raises Viking Holdings price target

Goldman Sachs raises Viking Holdings price target to $95 on strong 2027 bookings and pricing growth.

0
Today / 09:52
|
433

Goldman Sachs Raises KGS Target to $88 on Power Growth

Goldman Sachs raises Kodiak Gas Services price target to $88 on power growth. Strong earnings and expansion plans drive optimism.

0
Today / 08:53
|
541

Oppenheimer Downgrades Crescent BDC on Weak Returns

Oppenheimer downgrades Crescent BDC to Perform, cuts price target to $16. Stock at $11.99, weak Q1 results.

0
Today / 08:50
|
329

BofA Reiterates Buy on Alphabet Stock

BofA Securities reiterated a Buy rating on Alphabet stock ahead of its developer event. Get insights on AI announcements and stock performance.

0
Today / 08:32
|
977

Morgan Stanley Downgrades Aardvark Stock

Morgan Stanley downgrades Aardvark Therapeutics stock to Underweight, price target $3, after FDA clinical hold on ARD-101 over safety concerns.

0
Today / 08:22
|
238

Canaccord cuts Sangoma stock rating

Canaccord downgrades Sangoma stock rating due to weak results and pricing pressure. Price target cut to $4.

0
...